Bryostatin 1 in Treating Patients With Stage IV Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: bryostatin 1
Sponsor: University of Colorado, Denver
Collaborators: National Cancer Institute (NCI)